About the Targeted Chemotherapy Session
Targeted chemotherapy represents a significant advancement in cancer treatment, offering a more precise and less harmful approach compared to traditional chemotherapy. This method involves delivering chemotherapy drugs directly to cancer cells, sparing healthy tissue from damage and reducing side effects. Through innovative techniques such as monoclonal antibodies and nanoparticles, researchers can specifically target cancer cells based on their unique characteristics, such as surface proteins or genetic mutations. By honing in on these specific targets, targeted chemotherapy not only enhances treatment efficacy but also minimizes collateral damage to the body. This tailored approach holds promise for improving patient outcomes and quality of life, ushering in a new era of precision medicine in cancer care.
Topics Covered in Targeted Chemotherapy
Antibody-Drug Conjugates
Nanoparticle Carriers
Ligand-Targeted Delivery
Tumor-Selective Prodrugs
Regional Drug Delivery
Tumor Penetration Barriers
Related Scientific Sessions at CIOC 2027
Why Attend the Targeted Chemotherapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Targeted Chemotherapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Targeted Chemotherapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Targeted Chemotherapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Targeted Chemotherapy Conference 2027 — FAQs
What is the Targeted Chemotherapy track at CIOC 2027?
The Targeted Chemotherapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Targeted Chemotherapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Targeted Chemotherapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Targeted Chemotherapy are all welcome — whether presenting or attending.
Can I present my research in the Targeted Chemotherapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Targeted Chemotherapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Targeted Chemotherapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.